Mountain West AIDS Education and Training Center (MWAETC)

OD presentation return node

« Return to MWAETC On-Demand Presentations

Legacy Patients on Chronic High-Dose Opioids: Assessing Risks, Tapering, and Buprenorphine Rotation

Presentation Date: 2021-09-07

Presentation Length: 59:28

Presenters: James Darnton, MD

Presentation Categories: Addiction Series

Presentation Tags: Opioid Use Disorder

Presentation Slides:

Presentation Downloads:

Related Documents:

Related Links:

Related Presentations:

Presentation Details:
Objectives:
- Develop a framework for determining risks of continuation vs. discontinuation for legacy patients on high-dose opioids for chronic non-cancer pain.
- Explore best-practices for successful tapering of opioids for those at high risk.
- Understand approaches to buprenorphine rotation for high risk patients who do not tolerate a taper.

Presentation Transcript:

MOUNTAIN WEST AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,982,063 with 0% financed with non-governmental sources. The content in presentations are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.